Assertio Holdings, Inc. (ASRT)
NASDAQ: ASRT · Real-Time Price · USD
11.64
+0.16 (1.39%)
Jan 22, 2026, 4:00 PM EST - Market closed
Assertio Holdings Market Cap
Assertio Holdings has a market cap or net worth of $74.69 million as of January 23, 2026. Its market cap has decreased by -11.50% in one year.
Market Cap
74.69M
Enterprise Value
21.62M
1-Year Change
-11.50%
Ranking
Category
Stock Price
$11.64
Market Cap Chart
Since December 1, 1998, Assertio Holdings's market cap has increased from $47.70M to $74.69M, an increase of 56.59%. That is a compound annual growth rate of 1.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 73.70M | 26.63% |
| Dec 31, 2025 | 58.20M | -30.05% |
| Dec 31, 2024 | 83.20M | -17.87% |
| Dec 29, 2023 | 101.30M | -51.23% |
| Dec 30, 2022 | 207.70M | 113.46% |
| Dec 31, 2021 | 97.30M | 154.05% |
| Dec 31, 2020 | 38.30M | -62.04% |
| Dec 31, 2019 | 100.90M | -56.28% |
| Dec 31, 2018 | 230.80M | -54.50% |
| Dec 29, 2017 | 507.30M | -54.28% |
| Dec 30, 2016 | 1.11B | 1.20% |
| Dec 31, 2015 | 1.10B | 15.87% |
| Dec 31, 2014 | 946.30M | 56.96% |
| Dec 31, 2013 | 602.90M | 73.60% |
| Dec 31, 2012 | 347.30M | 21.01% |
| Dec 30, 2011 | 287.00M | -14.46% |
| Dec 31, 2010 | 335.50M | 92.59% |
| Dec 31, 2009 | 174.20M | 106.89% |
| Dec 31, 2008 | 84.20M | -45.92% |
| Dec 31, 2007 | 155.70M | 7.75% |
| Dec 29, 2006 | 144.50M | -40.61% |
| Dec 30, 2005 | 243.30M | 30.04% |
| Dec 31, 2004 | 187.10M | -21.88% |
| Dec 31, 2003 | 239.50M | 627.96% |
| Dec 31, 2002 | 32.90M | -58.62% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alpha Teknova | 180.66M |
| Anika Therapeutics | 136.42M |
| Incannex Healthcare | 123.60M |
| Cardiol Therapeutics | 100.83M |
| Citius Oncology | 89.04M |
| Cumberland Pharmaceuticals | 70.60M |
| InterCure | 52.78M |
| Zhengye Biotechnology Holding | 52.13M |